VeriMomsalicyloyl pentapeptide-33은 임신 중 안전한가요?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
Related ingredients
Frequently asked questions
- salicyloyl pentapeptide-33은 임신 중 안전한가요?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
- salicyloyl pentapeptide-33은 모유 수유 중 안전한가요?
- No data on transfer into breastmilk or lactation effects were found. Given the molecule class (peptidic cosmetic ingredient with likely low dermal absorption) and absence of reproductive/lactation signals in regulatory/search sources, hazard and mechanism scores default to 0 and exposure is judged negligible for typical topical cosmetic use.
- salicyloyl pentapeptide-33은 아기 피부에 안전한가요?
- No infant‑specific toxicity data found. Because the ingredient is not demonstrably non‑absorbable and infant skin has higher surface‑area‑to‑weight and immature barrier, exposure score is increased by +1 (adult e=0 → infant e=1). No evidence specific to developmental or dermatologic hazard in 0–3 yr olds was identified.
- VeriMom은 salicyloyl pentapeptide-33을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 salicyloyl pentapeptide-33을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 salicyloyl pentapeptide-33 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.